Methods. We analyzed the clinical outcomes of 555 patients with laryngeal cancer staged pT3-pT4a who underwent OPHL.
Results. 5 years overall survival, disease-free survival, locoregional control, local control, laryngectomy-free survival and laryngeal function preservation rates were 84.6%, 84.2%, 86.3%, 90.6%, 93.3% and 91.2%, respectively. Disease-free survival, locoregional control and laryngeal function preservation prevalences were significantly affected by pT4a staging (68.1%, 71.7% and 78.0% respectively), while pN+ influenced only disease-free survival (≤72.6%) and locoregional control (≤79.6%).
Conclusions. in cases of laryngeal tumors at intermediate and selected advanced stage, also with sub-glottic extension, the choice of OPHL with a modular approach can be considered effective in terms of prognostic and functional results. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Literature addressing this topic is rich, and a number of surgical procedures have been described coping with the different patterns of endolaryngeal tumor site and spread. [5] [6] [7] [8] [9] Recently, the European Laryngological Society proposed a classification of the more commonly adopted procedures according to extent of resection, 10 including three types of OPHL: Type I -supraglottic, Type II -supracricoid and Type III -supratracheal. The latter, described in 2006, is based on resection of the entire glottic and subglottic sites and of the thyroid cartilage, sparing both or at least one functioning cricoarytenoid unit. 11 In our practice, extending the limits of resection, OPHL Type III enlarges the indications suggested by National Comprehensive Cancer Network (NCCN) and Italian Head and Neck Society (IHNS) guidelines for the treatment of laryngeal cancer with conservative surgery (T1-T2, N0 or selected T3): some problematic glottic cT3 (i.e. sub-glottic extension 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 12, 13 Even, albeit with great caution, the same practice can be considered as up-front option in very restricted cT4a cases, with minimal anterior extralaryngeal extension, when it is reasonable to expect an exclusive treatment.
Head & Neck
In this study, we present a multicentric retrospective outcome analysis of 555 patients with supraglottic/glottic laryngeal SCC in the intermediate/advanced stage, managed by OPHL type II or III. The analysis was conducted over a 16-year period, during which organpreservation protocols with chemoradiotherapy or total laryngectomy were applied as conventional therapeutic options for these types of locally advanced tumors. 2, 4
Material and Methods

Patients
All patients were from the Hospital of Vittorio Veneto, Treviso, or the Martini Hospital of Turin. Selection was based on routinely performed clinical assessment lasting 3 weeks prior surgery, in order to evaluate the superficial and depth extent of the tumor, as previously described. 12 Inclusion criteria were histological diagnosis of intermediate/advance stage glottic or supraglottic laryngeal SCC, with Karnofsky index 14 higher than 80.
Exclusion criteria were severe diabetes mellitus, severe bronchopulmonary chronic obstructive disease, neurological problems impairing the ability to expectorate and/or swallow, or severe cardiac disease. Advanced age, an important cut-off for relative surgical indication, 15 has not been considered, in itself, an exclusion criterion. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 glottic pT4a) and 82 cases with fixed vocal cord and cricoarytenoid joint (48 glotticsubglottic pT3, 33 glottic pT4a, and 1 transglottic pT3).
Resections were classified according to the European Laryngological Society Classification. 10 In particular, only Type II and III OPHLs were performed: Type IIa (supracricoid partial laringectomy/crico-hyoido-epiglottopexy) = 62 (11.1%), Type IIa + ARY = 243 (43.8%), Type IIb (supracricoid partial laringectomy/crico-hyoido-pexy) = 32 (5.8%), Type IIb + ARY = 117 (21,1%), Type IIIa (supratracheal partial laryngectomy/tracheo-hyoido-epiglottopexy) = 9 (1.6%), Type IIIa + CAU = 82 (14.8%), Type IIIb (supratracheal partial laryngectomy/tracheo-hyoido-pexy) = 4 (0.7%), Type IIIb + CAU = 6 (1.1%), where "+ARY" represents the removal of one arytenoid and "+CAU" the removal of one cricoarytenoid unit.
The indications adopted for Type II (a+b) OPHLs were the classical ones, applied according to tumor extent, now being accepted and advocated by numerous authors. 6, 7, 9, 16 Although definitions for the Type III (a+b) OPHLs were only recently introduced, the precise indications and contraindications adopted were those already described in our previous study for tumors in the intermediate/selected T classification. 12 Anyway, a further contraindications to Type III (a+b) OPHLs and related to locoregional extent was supraglottic T4a tumors reaching the base of the tongue or invading the hyoid bone.
In all patients, resection margins were examined intraoperatively with frozen sections: when positive, the resection was expanded until the margins were negative. As the interventions were conducted using the principles of a modular approach, the resection is always prepared in standard mode and the larynx is opened from the side less affected by disease. At this point, under visual control, the subsites involved are removed and the resection can be easily enlarged as follows: (1) Patients underwent the same rehabilitation protocol, apart from those with serious early complications.
The postoperative protocol was in accord with our previous report. 12 Briefly: (1) A large volume encompassing the primary site and all draining lymph nodes was irradiated with a dose of up to 54 Gy/2 Gy. Regions at higher risk for malignant dissemination received a 12-Gy boost (total 66 Gy/2 Gy -range 62-68 Gy). Forty-two of 72 patients also received 100 mg/m 2 cisplatin on days 1, 22, and 43 of the course of radiotherapy. 19 
Larynx functional assessment
Pearson's scale evaluation was repeated and larynx functional status was evaluated with the Performance Status Scale throughout five post-operative years. 20
Statistical methods
Overall survival (OS), disease free survival (DFS), disease specific survival (DSS), locoregional control (LRC), local control (LC), laryngectomy free survival (LFS) and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 All analyses were performed with GraphPad Prism version 5.00 (GraphPad Software, San
Diego CA), with p < .05 as the significant cutoff.
Results
Patients
A cohort of 555 patients undergoing Type II or III OPHLs was considered ( Table 1) .
Current or former smokers made up 93% of the cohort. Patients were followed for a mean period of 5.57 years.
Pathology
All patients suffered of a biopsy-proven supraglottic or glottic laryngeal SCC, which it was classified as pT3 or pT4a, according to the 2002 TNM classification system 21 (Table 1) . We assessed also the impact of eventual previous treatment and age ≥65 without retrieving any significant differences (data not shown).
Patterns of failure
Locoregional recurrences affected 66 patients within 5 years of surgery. According to the site of pathology, they were sub-grouped as 40 local (60.6%), 5 locoregional (7.6%) and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 recurrences were observed at the VI level.
Four recurrences in the neck were treated with surgery alone, twenty with surgery and adjuvant radiation therapy and/or chemotherapy, two recurrences with chemotherapy. 11
patients died due to regional recurrences (range 6-38 months, mean 16.3 months), 2 patients died of other disease while at the last follow-up, 3 patients were alive with disease and 10 patients were alive and disease-free.
Postoperative course and morbidity
Overall, acute complications during hospitalization occurred in 62 out 555 patients (11.2%) and there were 3 perioperative deaths. The mean hospitalization time for patients with acute complications was 32 ± 6 days, which was significantly longer than that for patients without acute complications (21 ± 5 days). Late sequelae following discharge were observed in 85 out of 555 cases (15.3%) ( Table 3 ). All were successfully treated with transoral CO 2 laser surgery (68/85, 80%), revision of the pexy (2/85, 2.3%), injective laryngoplasty using Vox-implants, which successfully treated dysphagia (5/85, 5.8%), completion laryngectomy (5/85, 5.8%), or other endoscopic procedures (5/85, 5.8%).
Laryngeal function preservation
At 5 years after surgery, LFP rate was 92.6% (514 out 555 patients) while LFS resulted 93.3% (524 out 555 patients) ( Figure 3 ). In addition, we evaluated whether LFP could be affected by local or regional staging, presence of previous treatment, or age ≥65 years ( Figure 4 ). Patients affected by advanced pT stage were statistically significantly more prone to lose laryngeal function (78.0%) with respect to intermediate pT stage (94.2%). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The mean time to intermittent occlusion of the tracheostomy was 24.6 days (range 3-406 days), and the average time to tracheostomy closure was 82.4 days (range 23-489 days).
In our protocol, progressive closure of the tracheostomy is preferred, and occurs spontaneously in the majority of patients following occlusion. For patients, especially in the first weeks after discharge, this leads to a sensation of greater safety concerning minor episodes of food inhalation, which are relatively frequent. When the tracheostomy has almost closed, minor plastic surgery can then be performed.
Discussion
Notwithstanding that the preservation of laryngeal function is one of the major advances that have been achieved over the past decades, cancer of the larynx in the intermediate/advance stage still presents a major challenge in terms of controlling the disease and preserving the larynx, regardless of the therapeutic option chosen. 2-4, 6, 7, 9, 22-25 In fact, many glottic cT3 tumors with sub-glottic extent (vocal cord and arytenoid fixation) often result in early pT4a for extralaryngeal extent, making them of difficult management with chemoradiotherapy or supracricoid laryngectomy. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In this study, we have analyzed the outcomes of 555 patients affected by III-IV staged laryngeal SCC undergoing function sparing OPHL protocols. For the sake of clarity, we report in our cohort an higher percentage of glottic tumors (91.2%) than in previously described trials or case series for the great number of transglottic cancers (27.4%), which were included and being these always considered to originate from the glottis.
During the surgery, the open partial resection was tailored under visual control to obtain disease-free safe margins, which can be as close as of only 4-5 mm. It is important to note that such intra-surgery flexibility can be useful to address the heterogeneity of tumors on the base of their true extent. In our series, in fact, upstaging of cT3 to pT4a was found in 14.9% of specimens, generally due to the full thickness involvement of the thyroid lamina, and of cN0 to pN+ in 3% of cases, in spite of preoperative neck CT and/or MRI.
Being aware of these, otherwise not identifiable, upstaging may represent an explanation of the differences we already reported 12 and here further confirmed, in terms of local In fact, data concerning survival and disease control do not display significant differences with respect to our previous analysis, 12 but highlighted great differences with literature data concerning non-surgical approaches. In the present study, the 5-year OS was 84.6% and results better than what previously reported for both concomitant chemoradiotherapy or induction chemotherapy and radiotherapy (~60%). 4, 26 More advanced pT4a tumors displayed a 5-year DFS of 68.1%, a result in line with that of the most demolitive surgical approach, although it must be admitted that in these cases the extralaryngeal extension was minimal. These data show that a careful selection can render eligible for the partial modular surgical approach a good number of patients, even in some, very well selected "extreme cases". However, the DFS for pT4a cancer (68.2%) was significantly lower than that for pT3 classification (87.9%), but higher than that obtained by management with radiotherapy and/or chemoradiotherapy, which ranged from 26% to 38%, respectively. 4, 26 .
Finally, the number of patients which were subjected to total laryngectomy for either functional or oncological purposes was significantly low (6.2%) and there were only three perioperative deaths. The high laryngectomy-free survival rate here achieved deposed to the great potentiality of OPHL approaches in preserving the larynx. In summary, "everybody loses a piece, but few lose all".
Otherwise, larynx function preservation takes great advantages by tailoring surgery on the real extent of tumor, and significant differences (p < .001) are found after 5 years from surgery between OPHL type II (94.4%) and Type III (74.5%) patients. Here is important to note that the latter is consistent with our previous report (78.5%), 12 which was itself in line with that achievable with concomitant chemoradiation. As a consequence, maintenance of laryngeal function was more critical in patients affected by pT4a cancer (78.0%) and in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 13 Despite the employment of the less extended OPHL Type II, no differences in terms of acute complication and late sequelae were highlighted with respect to our previous analysis. 12 In fact, 19 out of 41 cases of aspiration pneumonia occurred in elderly patients, in whom gastrostomy was maintained in two patients owing to repeated episodes of aspiration pneumonia, and one was subjected to total laryngectomy. Fortunately these phenomena are not frequent, tend to self-restraint and to be well tolerated by patients. On the other 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In all cases in which the extent of the tumor determines the indication for a more extreme Type III partial laryngectomy (and this occurs for most tumors with sub-glottic extension or extension towards the posterior commissure), this imposes a serious ethical consideration.
In fact, in many specialized centers, these cases are considered to be "amenable with total laryngectomy" and therefore, up-front directed to non-surgical treatment in order to spare the larynx. When discussing a conservative surgical option with the patient, it must be explained clearly that if the resection margins are positive in frozen sections, the option immediately following that is total laryngectomy, thus "jumping" the option of concomitant chemoradiotherapy, which has a degree of recommendation IA. For these reasons, especially when the tumor clearly extends beyond the limits of the larynx, both the severity of the intervention and the necessity for adjuvant radiotherapy demand that extreme caution be taken when considering the indications.
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